Page 7 - Megan Paul News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Maru Appoints Erica Ruyle Managing Director, Qualitative
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Interpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiR
March 17, 2021 07:30 ET | Source: Interpace Biosciences, Inc. Interpace Biosciences, Inc.
Part of Company’s Site Consolidation and Cost Savings Measures
Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredited laboratory to DiamiR Biosciences, Corp. (DiamiR). This sale is in line with previously announced restructuring and cost reduction initiatives announced by Interpace. Under this agreement, DiamiR will provide overflow lab testing in support of the Company’s molecular thyroid testing products at its main laboratory in Pittsburgh, PA. DiamiR will also support specific Interpace assay development and validation services on behalf of the Company for the next three quarters. Subject to specific terms and conditions of
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020
GAITHERSBURG, Md., March 11, 2021 (GLOBE NEWSWIRE) OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter and full year 2020 financial results after the close of the U.S. financial markets on Thursday, March 25, 2021. OpGen’s management team will host a live conference call and audio webcast at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide an update on business activities.
Conference Call Details
13717232
Following the conclusion of the conference call, a replay will be available through April 8, 2021. The live, listen-only webcast of the conference call may also be accessed by visiting the Investors section of the Company’s website at www.opgen.com. A replay of the webcast will be available following the conclusion of the call and will be
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of .
OpGen, Inc.March 8, 2021 GMT
Karolinska Institutet Study highlights Unyvero HPN demonstrating a higher diagnostic yield than bacterial culture, enabling rapid diagnosis of pathogens of concern in these patients
High negative predictive value of 99.8% may allow for reduction in unnecessary antibiotic use and support antibiotic stewardship efforts
Performance data, comprehensive coverage and turnaround time of less than 5 hours from sample to result of this panel
provides clinicians earlier data to inform antimicrobial decisions, especially in critically ill COVID-19 patients during flu season
BJ s Restaurant & Brewhouse® Launches New BJ s Brewhouse Beer Club Across California
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
vimarsana © 2020. All Rights Reserved.